Ultra-sensitive CA 125 assay for personalized screening of early ovarian cancer using a novel immuno-mass spectrometric platform
Ultra-sensitive CA 125 assay for personalized screening of early ovarian cancer using a novel immuno-mass spectrometric platform
使用新型免疫质谱平台进行超灵敏 CA 125 检测，用于早期卵巢癌的个性化筛查
批准号：
376070
负责人：
Li Huiyan
金额：
$10.93万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-11-01 至 2020-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer is one of the most serious cancers for women, and although it ranks as only the 5th most common women's cancer, its average 5-year survival rate is only 45%. It is well accepted that early diagnosis is the key to extend survival in ovarian
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
